Literature DB >> 9135136

Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization.

P L Stewart1, C Y Chiu, S Huang, T Muir, Y Zhao, B Chait, P Mathias, G R Nemerow.   

Abstract

Interaction of the adenovirus penton base protein with alpha v integrins promotes virus entry into host cells. The location of the integrin binding sequence Arg-Gly-Asp (RGD) on human type 2 adenovirus (Ad2) was visualized by cryo-electron microscopy (cryo-EM) and image reconstruction using a mAb (DAV-1) which recognizes a linear epitope, IRGDTFATR. The sites for DAV-1 binding corresponded to the weak density above each of the five 22 A protrusions on the adenovirus penton base protein. Modeling of a Fab fragment crystal structure into the adenovirus-Fab cryo-EM density indicated a large amplitude of motion for the Fab and the RGD epitope. An unexpected finding was that Fab fragments, but not IgG antibody molecules, inhibited adenovirus infection. Steric hindrance from the adenovirus fiber and a few bound IgG molecules, as well as epitope mobility, most likely prevent binding of IgG antibodies to all five RGD sites on the penton base protein within the intact virus. These studies indicate that the structure of the adenovirus particle facilitates interaction with cell integrins, whilst restricting binding of potentially neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135136      PMCID: PMC1169718          DOI: 10.1093/emboj/16.6.1189

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  32 in total

1.  Angular reconstitution: a posteriori assignment of projection directions for 3D reconstruction.

Authors:  M Van Heel
Journal:  Ultramicroscopy       Date:  1987       Impact factor: 2.689

2.  The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution.

Authors:  R Acharya; E Fry; D Stuart; G Fox; D Rowlands; F Brown
Journal:  Nature       Date:  1989-02-23       Impact factor: 49.962

3.  Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor.

Authors:  P Seth; D Fitzgerald; H Ginsberg; M Willingham; I Pastan
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

4.  Cryo-electron microscopy of viruses.

Authors:  M Adrian; J Dubochet; J Lepault; A W McDowall
Journal:  Nature       Date:  1984 Mar 1-7       Impact factor: 49.962

5.  Enteric adenoviruses.

Authors:  G Wadell; A Allard; M Johansson; L Svensson; I Uhnoo
Journal:  Ciba Found Symp       Date:  1987

6.  Binding of adenovirus and its external proteins to Triton X-114. Dependence on pH.

Authors:  P Seth; M C Willingham; I Pastan
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

7.  Role of vesicles during adenovirus 2 internalization into HeLa cells.

Authors:  U Svensson
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

8.  Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.

Authors:  T J Smith; E S Chase; T J Schmidt; N H Olson; T S Baker
Journal:  Nature       Date:  1996-09-26       Impact factor: 49.962

9.  Determination of the nucleotide sequence for the penton-base gene of human adenovirus type 5.

Authors:  R Neumann; J Chroboczek; B Jacrot
Journal:  Gene       Date:  1988-09-15       Impact factor: 3.688

10.  Adenovirus-induced release of epidermal growth factor and pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocytosis.

Authors:  D J FitzGerald; R Padmanabhan; I Pastan; M C Willingham
Journal:  Cell       Date:  1983-02       Impact factor: 66.850

View more
  58 in total

Review 1.  Adding the third dimension to virus life cycles: three-dimensional reconstruction of icosahedral viruses from cryo-electron micrographs.

Authors:  T S Baker; N H Olson; S D Fuller
Journal:  Microbiol Mol Biol Rev       Date:  1999-12       Impact factor: 11.056

2.  Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin.

Authors:  C Y Chiu; P Mathias; G R Nemerow; P L Stewart
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Integrin alpha(v)beta1 is an adenovirus coreceptor.

Authors:  E Li; S L Brown; D G Stupack; X S Puente; D A Cheresh; G R Nemerow
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein.

Authors:  Natalya Belousova; Valentina Krendelchtchikova; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Flexibility of the adenovirus fiber is required for efficient receptor interaction.

Authors:  Eugene Wu; Lars Pache; Dan J Von Seggern; Tina-Marie Mullen; Yeshi Mikyas; Phoebe L Stewart; Glen R Nemerow
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

6.  Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer model.

Authors:  Lena J Gamble; Hideyo Ugai; Minghui Wang; Anton V Borovjagin; Qiana L Matthews
Journal:  J Mol Biochem       Date:  2012-02-15

7.  Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry.

Authors:  Aravind Asokan; Julie B Hamra; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Richard J Samulski
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 8.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

9.  Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein.

Authors:  Sayuri E Kato; Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

10.  Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors.

Authors:  Saw See Hong; Nagy A Habib; Laure Franqueville; Steen Jensen; Pierre A Boulanger
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.